A phase I trial of 5azacitidine and suberoylanilide hydroxamic acid in patients with metastatic or locally recurrent nasopharyngeal carcinoma and nasal NK-T cell lymphoma.

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 23 Aug 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

03 Jun 2013 Planned end date changed from 1 Aug 2007 to 1 May 2014 as reported by ClinicalTrials.gov record.
03 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
23 Oct 2007 Status change from suspended to recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com